Made by SterisWHO-GMP

Glimiteris Trio 0.5/0.2/500

by Steris Healthcare Pvt. Ltd.

Be the first to review

Glimepiride 0.5 mg + Voglibose 0.2 mg + Metformin Hydrochloride 500 mg

GLIMITERIS TRIO 0.5/0.2/500 by Steris Healthcare is a triple-combination oral antidiabetic medicine containing Glimepiride 0.5 mg, Voglibose 0.2 mg, and Metformin Hydrochloride (SR) 500 mg. It is prescribed for the management of type 2 diabetes mellitus along with a healthy diet and regular physical activity.

View medicine information ↓
Choose a pack
₹100.41₹143.4430% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹5.02 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

GLIMITERIS TRIO 0.5/0.2/500 is a triple-combination antidiabetic tablet marketed by Steris Healthcare. It contains Glimepiride 0.5 mg, Voglibose 0.2 mg, and Metformin Hydrochloride Sustained Release (SR) 500 mg. This combination is designed to help manage blood glucose levels in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional. Each active ingredient works through a different mechanism. Glimepiride stimulates insulin release from the pancreas, Metformin Hydrochloride helps reduce glucose production in the liver and improves insulin sensitivity, and Voglibose helps slow carbohydrate absorption in the intestine. Together, these medicines support blood sugar management as part of an individualized diabetes treatment plan. GLIMITERIS TRIO 0.5/0.2/500 should be used under medical supervision, alongside dietary management, physical activity, and regular blood glucose monitoring. The dosage and duration of treatment should be determined by the treating physician according to the patient's clinical condition and treatment response.

How to use

Take GLIMITERIS TRIO 0.5/0.2/500 exactly as prescribed by your doctor. Follow the prescribed dose and timing in relation to meals, as directed by your healthcare professional. Because the product contains sustained-release Metformin, swallow the tablet according to the instructions on its approved packaging; do not crush or chew it unless specifically permitted by the product information. Do not change the dose or discontinue treatment without medical advice. Monitor your blood glucose as recommended and follow your prescribed meal plan and exercise routine. Contact your doctor if you experience symptoms of low blood sugar, persistent gastrointestinal discomfort, or other unexpected side effects.

Storage

Store GLIMITERIS TRIO 0.5/0.2/500 according to the storage instructions printed on the product packaging. Keep the tablets in their original packaging, protected from excessive heat and moisture. Keep the medicine out of the reach of children. Do not use the tablets after the expiry date. Dispose of unused or expired medicine responsibly in accordance with local pharmaceutical disposal guidance.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid excessive alcohol consumption and consult your doctor about alcohol use, as it may increase the risk of adverse effects, including low blood sugar and, in certain circumstances, metformin-associated lactic acidosis.

PregnancyConsult your doctor

Consult your doctor before using this medicine if you are pregnant, planning a pregnancy, or suspect you may be pregnant. Your treatment may need to be changed.

BreastfeedingConsult your doctor

Seek medical advice before taking this medicine while breastfeeding.

DrivingConsult your doctor

Glimepiride may cause hypoglycaemia, which can affect concentration and reaction time. Check your blood glucose when appropriate and avoid driving if you experience symptoms of low blood sugar, dizziness, or weakness.

KidneyConsult your doctor

Inform your doctor if you have kidney disease or reduced kidney function. Metformin may not be suitable for certain levels of renal impairment, and kidney function may require monitoring.

LiverConsult your doctor

Tell your doctor if you have liver disease, as it may affect the suitability and safety of treatment.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Your feedback helps other customers make informed choices.

0/3000 charactersChecking your sign-in status…

Frequently viewed together

Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch
Rx · H
Linaliglip Empamet product pack

Linaliglip Empamet

For 15 Tablets

Empagliflozin 25 mg + Linagliptin 5 mg + Metformin 1000 mg

No reviews
₹154.00₹220.0030% off
Prescription required before dispatch
Rx · H
Acarbzone M 500 product pack

Acarbzone M 500

For 10 Tablet

Acarbose 50 mg + Metformin 500 mg

No reviews
₹108.22₹154.6030% off
Prescription required before dispatch
Rx · H
Acarbzone 25 product pack

Acarbzone 25

For 10 Tablet

Acarbose 25 mg

No reviews
₹52.83₹75.4730% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.